USE OF CARPIPRAMINE IN THE TREATMENT OF PSYCHIATRIC DISORDERS AND DEVELOPMENT IN CHILDREN AND ADOLESCENTS

摘要

The present invention therefore relates to a selection of patients and their treatment with carpipramine, according to criteria relating to the property of carpipramine preferentially block the alpha2C subtype, which can serve, on the one hand, to characterize patients who can benefit from treatment with carpipramine, and to exclude those with disorders that can not be improved with carpipramine.